Evidence map›Paper›PMID 27824876›Full record

ArticlePloS one2016

Understanding the Role of Accredited Drug Dispensing Outlets in Tanzania's Health System.

Martha Embrey, Catherine Vialle-Valentin, Angel Dillip, Bernard Kihiyo, Romuald Mbwasi, Innocent A Semali, John C Chalker, Jafary Liana, Rachel Lieber, Keith Johnson and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Reaching Adolescent Girls and Young Women With HIV Self-Testing and Contraception at Girl-Friendly Drug Shops: A Randomized Trial in Tanzania.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2023
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Martha EmbreyPharmaceuticals & Health Technologies Group, Management Science for Health, Arlington, Virginia, United States of America.ORCID http://orcid.org/0000-0002-2556-6487
Catherine Vialle-ValentinDrug Policy Research Group, Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
Angel DillipIfakara Health Institute, Dar es Salaam, Tanzania.
Bernard KihiyoTanzania Consumer Advocacy Society, Dar es Salaam, Tanzania.
Romuald MbwasiApotheker Consultancy (T) Limited, St. Johns University of Dodoma, Dodoma, Tanzania.
Innocent A SemaliSchool of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
John C ChalkerPharmaceuticals & Health Technologies Group, Management Science for Health, Arlington, Virginia, United States of America.
Jafary LianaPharmaceuticals & Health Technologies Group, Management Science for Health, Dar es Salaam, Tanzania.
Rachel LieberPharmaceuticals & Health Technologies Group, Management Science for Health, Arlington, Virginia, United States of America.
Keith JohnsonPharmaceuticals & Health Technologies Group, Management Science for Health, Arlington, Virginia, United States of America.
Edmund RuttaPharmaceuticals & Health Technologies Group, Management Science for Health, Arlington, Virginia, United States of America.
Suleiman KimattaPharmaceuticals & Health Technologies Group, Management Science for Health, Dar es Salaam, Tanzania.
Elizabeth ShekalaghePharmacy Council of Tanzania, Dar es Salaam, Tanzania.
Richard ValimbaPharmaceuticals & Health Technologies Group, Management Science for Health, Dar es Salaam, Tanzania.
Dennis Ross-DegnanDrug Policy Research Group, Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
Management and Development for Health · TZHarvard University · USIfakara Health Institute · TZMuhimbili University of Health and Allied Sciences · TZThe University of Dodoma · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPeople in many low-income countries access medicines from retail drug shops. In Tanzania, a public-private partnership launched in 2003 used an accreditation approach to improve access to quality medicines and pharmaceutical services in underserved areas. The government scaled up the accredited drug dispensing outlet (ADDO) program nationally, with over 9,000 shops now accredited. This study assessed the relationships between community members and their sources of health care and medicines, particularly antimicrobials, with a specific focus on the role ADDOs play in the health care system.

methodsUsing mixed methods, we collected data in four regions. We surveyed 1,185 households and audited 96 ADDOs and 84 public/nongovernmental health facilities using a list of 17 tracer drugs. To determine practices in health facilities, we interviewed 1,365 exiting patients. To assess dispensing practices, mystery shoppers visited 306 ADDOs presenting one of three scenarios (102 each) about a child's respiratory symptoms. RESULTS AND DISCUSSION: Of 614 household members with a recent acute illness, 73% sought outside care-30% at a public facility and 31% at an ADDO. However, people bought medicines more often at ADDOs no matter who recommended the treatment; of the 581 medicines that people had received, 49% came from an ADDO. Although health facilities and ADDOs had similar availability of antimicrobials, ADDOs had more pediatric formulations available (p<0.001). The common perception was that drugs from ADDOs are more expensive, but the difference in the median cost to treat pneumonia was relatively minimal (US$0.26 in a public facility and US$0.30 in an ADDO). Over 20% of households said they had someone with a chronic condition, with 93% taking medication, but ADDOs are allowed to sell very few chronic care-related medicines. ADDO dispensers are trained to refer complicated cases to a health facility, and notably, 99% of mystery shoppers presenting a pneumonia scenario received an antimicrobial (54%), a referral (90%), or both (45%), which are recommended practices for managing pediatric pneumonia. However, one-third of the dispensers needlessly sold antibiotics for cold symptoms, and 85% sold an antibiotic on request. In addition, the pneumonia scenario elicited more advice on handling the illness than the cold symptoms scenario (61% vs. 15%; p<0.0001), but overall, only 44% of the dispensers asked any of the shoppers about danger signs potentially associated with pneumonia in a child.

conclusionADDOs are the principal source of medicines in Tanzania and an important part of a multi-faceted health care system. Poor prescribing in health facilities, poor dispensing at ADDOs, and inappropriate patient demand continue to contribute to inappropriate medicines use. Therefore, while accreditation has attempted to address the quality of pharmaceutical services in private sector drug outlets, efforts to improve access to and use of medicines in Tanzania need to target ADDOs, public/nongovernmental health facilities, and the public to be effective.

Indexed as

Delivery of Health CareFamily CharacteristicsHealth Services AccessibilityHumansMedical AssistanceNonprescription DrugsPrivate SectorPublic-Private Sector PartnershipsTanzaniaNonprescription Drugs

Identifiers

PMID27824876
PMCPMC5100953
OpenAlexW2552562589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.